Chad Gassert - 11 Feb 2026 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
SVP - CORP. DEV. & STRATEGY
Signature
/s/ Chad Gassert, by attorney-in-fact Meredith W. Cook
Issuer symbol
ANIP
Transactions as of
11 Feb 2026
Net transactions value
-$325,511
Form type
4
Filing time
13 Feb 2026, 16:12:08 UTC
Previous filing
14 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gassert Chad SVP - CORP. DEV. & STRATEGY C/O ANI PHARMACEUTICALS, INC., 210 MAIN STREET WEST, BAUDETTE /s/ Chad Gassert, by attorney-in-fact Meredith W. Cook 13 Feb 2026 0001871002

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Tax liability $325,511 -4,269 -5.8% $76.25 69,346 11 Feb 2026 Direct F1
holding ANIP Common Stock 158,490 11 Feb 2026 Held by Chali Properties LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 11,578 performance stock units, the grant of which was previously reported on April 6, 2023.
F2 The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC.